Stephanie Notley in Palm Springs, California

Home California Palm Springs

Stephanie Notley has Nurse Practitioner as her primary medical specialty. Their primary office is: 1150 N Indian Canyon Dr in Palm Springs, California.

They're a part of the: Cep America - Neurology Pc medical group which has around 56 members. You can call their office at 760-323-6511 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Columbia University College Of Physicians And Surgeons and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Stephanie Au Notley Office Phone and Directions

Stephanie Notley
Cep America - Neurology Pc
1150 N Indian Canyon Dr
Palm Springs, California 92262
760-323-6511

Patient Ratings
Please rate your experience with Stephanie Notley below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 760-323-6511

Enter a starting address:

Healthcare Info for Stephanie Notley

Medical School: Columbia University College Of Physicians And Surgeons
Graduation Year: 2018
The Primary Medical Specialty for Stephanie Notley is listed as: Nurse Practitioner
Approximate Years of Experience: 6
PAC (PECOS ID)#: 3678904562
NPI #: 1528597242
NPI Created On: 06/06/2017
NPI Last Updated Listed as: 12/30/2022
Primary Taxonomy Code: 163W00000X
License Number:
702224
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $160

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 836083189

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Virology & Specialty Care

Name of Drug #1: Xofluza

Open Associated Drug #1: 50242-828-02